Pilocytic Astrocytoma in a Young Adult Male: Case-Based Review with Neuroimaging Quiz and Expert Commentary

on

 

Pilocytic Astrocytoma in a Young Adult Male: Case-Based Review with Neuroimaging Quiz and Expert Commentary

Introduction

Headache, nausea, and vomiting are common neurological complaints that can range from benign to life-threatening conditions. In young adults, these symptoms warrant a high index of suspicion for intracranial pathology. We present the case of a man in his 20s who presented with classic signs of increased intracranial pressure and was ultimately diagnosed with pilocytic astrocytoma of the midbrain—a rare but critical CNS tumor.

This blog post is a comprehensive, expert-level analysis optimized for Google SEO and AdSense compliance, including a case summary, imaging quiz, detailed discussion on the disease entity, and academic references.

Clinical Case Summary

Patient: Male, 20s
Chief Complaints: Headache, nausea, vomiting
Initial Imaging: Non-contrast head CT
Findings: Hypodense, round lesion centered in the right midbrain with mass effect on the third and fourth ventricles, causing obstructive hydrocephalus.

Further Imaging: Brain MRI with and without contrast (MPRAGE, T2, GRE, DWI, ADC, T1C+, coronal T1C+)

Diagnosis: Pilocytic Astrocytoma confirmed via surgical excision and pathology
Treatment: Tumor resection and ventriculoperitoneal (VP) shunt placement

Quiz

Quiz 1

Q1. There is evidence of obstructive hydrocephalus.
(1) True
(2) False
Answer: (1)
Explanation: Enlargement of the lateral and third ventricles with mass effect and disruption of CSF flow from the aqueduct confirms hydrocephalus.

Q2. Where is the salient lesion centered?
(1) Frontal lobe
(2) Midbrain
(3) Cerebellum
Answer: (2)
Explanation: Both CT and MRI reveal a lesion in the right midbrain extending to the superior cerebellar peduncle.

Quiz 2

Q3. The salient lesion is entirely solid.
(1)  True
(2)  False
Answer: (2)
Explanation: MRI shows a partially cystic and partially solid lesion, characteristic of pilocytic astrocytoma.

Q4. There is an area of increased susceptibility.
(1)  True
(2)  False
Answer: (2)
Explanation: GRE imaging shows blooming artifacts suggestive of hemorrhagic components.

Q5. Do the imaging features favor metastasis or primary CNS origin?
(1)  Primary CNS origin
(2)  Metastasis
Answer: (1)
Explanation: The imaging characteristics (cystic-solid nature, nodular enhancement, T2 heterogeneity) and patient age are consistent with a primary glial neoplasm.

Discussion

1. Cause and Etiology

Pilocytic astrocytomas are WHO Grade I gliomas arising from astrocytes. While commonly seen in the pediatric population, adult cases, especially in the midbrain, are rare. The tumor results from the aberrant proliferation of astrocytes, likely driven by mutations in the MAPK pathway, particularly alterations in the BRAF gene.

2. Pathophysiology

The hallmark pathophysiological process is the formation of a well-circumscribed, slow-growing lesion that may have cystic components. It can compress vital brain structures such as the aqueduct of Sylvius, leading to obstructive hydrocephalus, as seen in this case.

The lesion may also include:

  • Rosenthal fibers (in pathology)

  • Eosinophilic granular bodies

  • Microvascular proliferation

3. Epidemiology

  • Incidence: ~1.5 per 100,000 individuals/year

  • Most common in children and adolescents, rare in adults

  • Slight male predominance

  • Predominantly located in the cerebellum (60%), the optic pathway (20%), and the brainstem (<5%)

4. Clinical Presentation

Symptoms often reflect mass effect and increased intracranial pressure, including:

  • Persistent headache

  • Nausea and vomiting

  • Diplopia or cranial nerve deficits (in brainstem lesions)

  • Ataxia (if cerebellar involvement)

5. Imaging Features

CT Scan:

  • Hypodense or isodense lesion

  • Mass effect on adjacent ventricles

  • Associated hydrocephalus

MRI:

  • T1: Hypointense solid components

  • T2/FLAIR: Hyperintense cystic zones, heterogeneous solid parts

  • T1C+: Nodular and rim enhancement

  • GRE: Blooming artifacts indicating hemorrhage

  • DWI/ADC: No true restriction, differentiating from abscess or high-grade tumors

Characteristic Feature: "Cyst with enhancing mural nodule"

6. Treatment

  • Surgical Resection: Primary modality

  • CSF Diversion: VP shunt to relieve hydrocephalus

  • Radiation/Chemotherapy: Reserved for incomplete resections or recurrences

  • Targeted therapy: Ongoing trials using BRAF inhibitors in recurrent cases

7. Prognosis

  • Excellent for gross total resection (>90% 10-year survival)

  • Recurrence is rare in completely resected cases

  • Long-term surveillance MRI is recommended

Takeaway Points

  • Midbrain pilocytic astrocytoma is rare in adults but should be suspected in patients with obstructive hydrocephalus and midbrain mass.

  • MRI remains the gold standard for lesion characterization.

  • Gross total resection offers curative outcomes in most patients.

  • Radiology quiz tools aid in education and the recognition of diagnostic patterns.

References

  1. S. Louis et al., “The 2021 WHO Classification of Tumors of the Central Nervous System: a summary,” Acta Neuropathologica, vol. 142, no. 1, pp. 141–146, 2021.

  2. L. J. Ostrom et al., “CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States,” Neuro-Oncology, vol. 22, no. suppl 2, pp. iv1–iv96, 2020.

  3. M. A. Pajtler et al., “Molecular Classification of Pediatric Brain Tumors,” Nature Reviews Clinical Oncology, vol. 14, no. 8, pp. 442–455, 2017.

  4. H. Bandopadhayay et al., “Clinical Benefit of BRAF Inhibitors in Pediatric Low-Grade Gliomas,” Journal of Clinical Oncology, vol. 34, no. 29, pp. 3021–3026, 2016.

  5. R. F. Keating et al., “Surgical management of midbrain pilocytic astrocytomas,” Journal of Neurosurgery: Pediatrics, vol. 6, no. 4, pp. 281–289, 2010.

Comments

Post a Comment